Michaela S Tracy1,2, Prasanna K Challa2, Lauren Canha2, Kristin Burke2,3, Ashwin N Ananthakrishnan2,3, Emily W Lopes2,3, James M Richter3, Andrew T Chan2,3,4, Hamed Khalili5,6. 1. Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA. 2. Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA. 3. Division of Gastroenterology, Digestive Healthcare Center - Crohn's and Colitis Center, Massachusetts General Hospital and Harvard Medical School, 165 Cambridge Street, 9th Floor, Boston, MA, 02114, USA. 4. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. 5. Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA. hkhalili@mgh.harvard.edu. 6. Division of Gastroenterology, Digestive Healthcare Center - Crohn's and Colitis Center, Massachusetts General Hospital and Harvard Medical School, 165 Cambridge Street, 9th Floor, Boston, MA, 02114, USA. hkhalili@mgh.harvard.edu.
Abstract
BACKGROUND: Microscopic colitis is a chronic inflammatory disease that most commonly affects post-menopausal women. Exogenous hormone use has recently been linked with increased risk of microscopic colitis. Yet, it is unclear whether levels of endogenous sex hormones are also associated with risk of microscopic colitis. AIM: To evaluate the association between prediagnostic plasma androgens and subsequent risk of microscopic colitis. METHODS: We conducted a case-control study nested within prospective cohort studies of the Nurses' Health Study (NHS) and NHSII. Cases of microscopic colitis were each matched to two controls according to age, cohort, menopause status, fasting status, and season of plasma collection. Prediagnosis plasma levels of androgens including dehydroepiandrosterone sulfate, testosterone, and sex hormone-binding globulin were measured. We examined the association of each analyte with risk of microscopic colitis using conditional logistic regression models. RESULTS: Our study included 96 cases of microscopic colitis matched to 190 controls. Plasma levels of testosterone were not associated with risk of microscopic colitis (Ptrend = 0.70). Compared to participants in the lowest quartile of plasma testosterone levels, the aOR of microscopic colitis for women in the highest quartile was 0.88, 95% CI 0.45-1.71. Similarly, we did not observe an association between dehydroepiandrosterone sulfate and sex hormone-binding globulin and risk of microscopic colitis (all Ptrend > 0.52). CONCLUSION: Among women, prediagnostic circulating levels of testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin are not associated with risk of microscopic colitis.
BACKGROUND: Microscopic colitis is a chronic inflammatory disease that most commonly affects post-menopausal women. Exogenous hormone use has recently been linked with increased risk of microscopic colitis. Yet, it is unclear whether levels of endogenous sex hormones are also associated with risk of microscopic colitis. AIM: To evaluate the association between prediagnostic plasma androgens and subsequent risk of microscopic colitis. METHODS: We conducted a case-control study nested within prospective cohort studies of the Nurses' Health Study (NHS) and NHSII. Cases of microscopic colitis were each matched to two controls according to age, cohort, menopause status, fasting status, and season of plasma collection. Prediagnosis plasma levels of androgens including dehydroepiandrosterone sulfate, testosterone, and sex hormone-binding globulin were measured. We examined the association of each analyte with risk of microscopic colitis using conditional logistic regression models. RESULTS: Our study included 96 cases of microscopic colitis matched to 190 controls. Plasma levels of testosterone were not associated with risk of microscopic colitis (Ptrend = 0.70). Compared to participants in the lowest quartile of plasma testosterone levels, the aOR of microscopic colitis for women in the highest quartile was 0.88, 95% CI 0.45-1.71. Similarly, we did not observe an association between dehydroepiandrosterone sulfate and sex hormone-binding globulin and risk of microscopic colitis (all Ptrend > 0.52). CONCLUSION: Among women, prediagnostic circulating levels of testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin are not associated with risk of microscopic colitis.
Authors: Darrell S Pardi; Edward V Loftus; Thomas C Smyrk; Patricia P Kammer; William J Tremaine; Cathy D Schleck; W Scott Harmsen; Alan R Zinsmeister; L Joseph Melton; William J Sandborn Journal: Gut Date: 2006-11-29 Impact factor: 23.059
Authors: Janet G M Markle; Daniel N Frank; Steven Mortin-Toth; Charles E Robertson; Leah M Feazel; Ulrike Rolle-Kampczyk; Martin von Bergen; Kathy D McCoy; Andrew J Macpherson; Jayne S Danska Journal: Science Date: 2013-01-17 Impact factor: 47.728
Authors: Kristin E Burke; Ashwin N Ananthakrishnan; Paul Lochhead; Po-Hong Liu; Ola Olen; Jonas F Ludvigsson; James M Richter; Shelley S Tworoger; Andrew T Chan; Hamed Khalili Journal: Gastroenterology Date: 2018-08-23 Impact factor: 22.682
Authors: Helga Westerlind; Marie-Rose Mellander; Francesca Bresso; Andreas Munch; Ferdinando Bonfiglio; Ghazaleh Assadi; Joseph Rafter; Matthias Hübenthal; Wolfgang Lieb; Henrik Källberg; Boel Brynedal; Leonid Padyukov; Jonas Halfvarson; Leif Törkvist; Jan Bjork; Anna Andreasson; Lars Agreus; Sven Almer; Stephan Miehlke; Ahmed Madisch; Bodil Ohlsson; Robert Löfberg; Rolf Hultcrantz; Andre Franke; Mauro D'Amato Journal: Gut Date: 2015-11-02 Impact factor: 23.059
Authors: Hans Fischer; Elisabet Holst; Fredrik Karlsson; Cecilia Benoni; Ervin Toth; Martin Olesen; Måns Lindén; Klas Sjöberg Journal: Gut Date: 2015-04-03 Impact factor: 23.059
Authors: Hamed Khalili; Ashwin N Ananthakrishnan; Gauree G Konijeti; Leslie M Higuchi; Charles S Fuchs; James M Richter; Shelley S Tworoger; Susan E Hankinson; Andrew T Chan Journal: Inflamm Bowel Dis Date: 2015-06 Impact factor: 5.325